These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3992601)

  • 1. Reduction of ochratoxin A toxicity in mice treated with phenylalanine and phenobarbital.
    Moroi K; Suzuki S; Kuga T; Yamazaki M; Kanisawa M
    Toxicol Lett; 1985 Apr; 25(1):1-5. PubMed ID: 3992601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of 4-hydroxyochratoxin A from ochratoxin A by rat liver microsomes.
    Størmer FC; Pedersen JI
    Appl Environ Microbiol; 1980 May; 39(5):971-5. PubMed ID: 7396488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of phenobarbital pretreatment on digitoxin toxicity and biotransformation in guinea-pigs.
    Carvalhas ML; Figueira MA
    Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):35-43. PubMed ID: 543746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylalanine prevents acute poisoning by ochratoxina in mice.
    Creppy EE; Schlegel M; Röschenthaler R; Dirheimer G
    Toxicol Lett; 1980 Jul; 6(2):77-80. PubMed ID: 7414623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preventive action of phenylalanine on acute intoxication of ochratoxin-A].
    Creppy E; Schlegel M; Röschenthaler R; Dirheimer G
    C R Seances Acad Sci D; 1979 Nov; 289(13):915-8. PubMed ID: 121251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of phenobarbital pretreatment on the plasma and urinary levels of (-)-alpha-acetylmethadol and its metabolites.
    Kuttab SH; Nowshad F; Shargel L
    J Pharm Sci; 1985 Mar; 74(3):331-4. PubMed ID: 4009444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of ochratoxin A in rats.
    Suzuki S; Satoh T; Yamazaki M
    Jpn J Pharmacol; 1977 Oct; 27(5):735-44. PubMed ID: 592561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression by ochratoxin A and its prevention by phenylalanine.
    Haubeck HD; Lorkowski G; Kölsch E; Röschenthaler R
    Appl Environ Microbiol; 1981 Apr; 41(4):1040-2. PubMed ID: 7235701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of trans-4-acetylaminostilbene metabolism in the rat by methylcholanthrene and phenobarbital and its relevance for acute toxicity.
    Pfeifer A; Neumann HG
    Drug Metab Dispos; 1988; 16(2):276-84. PubMed ID: 2898347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity and excretion of ochratoxin A in rats intubated with pure ochratoxin A or fed cultures of Penicillium viridicatum.
    Van Walbeek W; Moodie CA; Scott PM; Harwig J; Grice HC
    Toxicol Appl Pharmacol; 1971 Nov; 20(3):4239-41. PubMed ID: 5132783
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite.
    Sarhan F; Engasser JM; Batt AM; Magdalou J; Siest G
    Eur J Drug Metab Pharmacokinet; 1981; 6(2):99-108. PubMed ID: 7306277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of phenobarbital and high doses of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the treatment of brain tumor-bearing mice.
    Muller PJ; Tator CH; Bloom ML
    Cancer Res; 1983 May; 43(5):2068-71. PubMed ID: 6831437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of ochratoxin A-induced inhibition of phenylalanine hydroxylase and its reversal by phenylalanine.
    Zanic-Grubisić T; Zrinski R; Cepelak I; Petrik J; Radić B; Pepeljnjak S
    Toxicol Appl Pharmacol; 2000 Sep; 167(2):132-9. PubMed ID: 10964764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cytochrome P450 induction on the metabolism and toxicity of ochratoxin A.
    Omar RF; Gelboin HV; Rahimtula AD
    Biochem Pharmacol; 1996 Feb; 51(3):207-16. PubMed ID: 8573185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of ochratoxin B and its possible effects upon the metabolism and toxicity of ochratoxin A in rats.
    Størmer FC; Kolsaker P; Holm H; Rogstad S; Elling F
    Appl Environ Microbiol; 1985 May; 49(5):1108-12. PubMed ID: 4004232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pretreatment with sodium phenobarbital on the toxicity of soman in mice.
    Clement JG
    Biochem Pharmacol; 1983 Apr; 32(8):1411-5. PubMed ID: 6860360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ochratoxin A: plasma concentration and excretion into bile and urine in albumin-deficient rats.
    Kumagai S
    Food Chem Toxicol; 1985 Oct; 23(10):941-3. PubMed ID: 4065769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fate of ochratoxin A in rats.
    Chang FC; Chu FS
    Food Cosmet Toxicol; 1977 Jun; 15(3):199-204. PubMed ID: 892675
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of macrophage migration by ochratoxin A and citrinin, and prevention by phenylalanine of the ochratoxin A-induced inhibition.
    Klinkert W; Lorkowski G; Creppy EE; Dirheimer G; Röschenthaler R
    Toxicol Eur Res; 1981 Jul; 3(4):185-9. PubMed ID: 7302945
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of aldo-keto reductases by phenobarbital alters metabolism, pharmacokinetics and toxicity of doxorubicin in rats.
    Behnia K; Boroujerdi M
    J Pharm Pharmacol; 1999 Nov; 51(11):1275-82. PubMed ID: 10632085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.